Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 3
- Countries
- 0
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8747888 | TWIRLAethinyl estradiol; levonorgestrel | product | Jul 2028 |
| 9050348 | TWIRLAethinyl estradiol; levonorgestrel | product | Jul 2028 |
| 8246978 | TWIRLAethinyl estradiol; levonorgestrel | product | Aug 2028 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Twirla | levonorgestrel/ethinyl estradiol | patch, transdermal | 71671-100NDA |
Enquiry
Common questions
- Is Agile Therapeutics, Inc. FDA approved?
- Agile Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Agile Therapeutics, Inc. make?
- 1 product is listed under Agile Therapeutics, Inc. in the openFDA NDC Directory, most often as patch. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.